8-K/A
Current Report
Theriva Biologics, Inc. Filed Acc 0001144204-06-045733
Material agreement · Auditor change · Change in control · Executive or director change · Shell status change
- Item 1.01 Entry into a material definitive agreement
- Item 4.01 Changes in the registrant's certifying accountant
- Item 5.01 Changes in control of the registrant
- Item 5.02 Departure or appointment of directors or officers
- Item 5.06 Change in shell company status
From the SEC's structured data for this filing
Loading v056705_8ka.htm…